EUVIMEDEUVIMED entdecken
Crossref

Regional Disparities and Unmet Needs in Long‐Term Durable Left Ventricular Assist Device Support Across Europe

Andrew Xanthopoulos iD, Dimitrios E Magouliotis iD, Katerina K Naka iD, Lampros K Michalis iD, Konstantinos Toutouzas iD, Serge Sicouri iD, Basel Ramlawi, Randall C Starling, Filippos Triposkiadis iD, John Skoularigis, Alexandros Briasoulis

Artificial Organs · 2026-05 · 50 (5) · 730-737

DOI: 10.1111/aor.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 05.01.2026. Verfasst von Andrew Xanthopoulos und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University General Hospital of Larissa, Faculty of Medicine, University of Thessaly, Larissa, Greece. Hauptthemen laut MEDLINE: Heart-Assist Devices, Healthcare Disparities, Heart Failure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite advances in durable left ventricular assist device (LVAD) technology and improved survival outcomes, significant disparities persist in its utilization across Europe, particularly in Southern regions.

Aims

To evaluate variability in LVAD implantation rates among representative European countries and estimate the unmet needs in Greece.

Methods

Market data reflecting the sales of long‐term LVAD systems across various countries from 2019 to 2024 were combined with registry‐based LVAD implantation records to estimate the number of eligible patients and actual LVAD implantations in selected European countries. A stepwise epidemiological modeling approach was applied to estimate LVAD‐eligible patients in Greece.

Results

In several Southern European countries, LVAD implantation rates in 2024 were no more than 2 per million population (Greece: 0.78/million, Italy: 1.89/million, Spain: 1.79/million, Portugal: 0.88/million). In Greece, even though an estimated 349 patients were eligible for LVAD implantation in 2024, based on demographic and clinical criteria, only seven devices were implanted while 24 patients underwent heart transplantation, reflecting a treatment gap of 318 patients (approximately 91% of the eligible population). In contrast, countries in Western and Northern Europe (Austria: 4.57/million, Germany: 8.74/million, France: 2.47/million, the Netherlands: 5.71/million, Switzerland: 3.28/million, Hungary: 2.08/million, Czech Republic: 6.19/million, Sweden: 2.19/million) reported LVAD implantation rates up to 9 per million. Significant discrepancies were reported also in the number of available LVAD centers as well as LVAD implantations per million between Greece and countries with similar populations (≈10 million residents) from Europe and Asia.

Conclusions

LVAD implantation rates vary among representative Southern European countries, with the lowest rates being observed in Greece. Insufficient number of implanting centers, limited reimbursement, and fragmented post‐implant care contribute to this disparity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHealthcare DisparitiesHeart FailureHumansEuropeMaleFemaleMiddle AgedRegistriesHeart TransplantationAdultAged

Stichwörter der Autor:innen

GreeceSouthern Europedestination therapyheart failureleft ventricular assist deviceregional disparity

Autor:innen und Institutionen

  • Department of Cardiology, University General Hospital of Larissa, Faculty of Medicine, University of Thessaly, Larissa, Greece.
  • School of Medicine, European University Cyprus, Nicosia, Cyprus.
  • Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, Pennsylvania, USA.
  • 2nd Cardiology Department, Ioannina University Hospital, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
  • First Department of Cardiology, Hippokration General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece.
  • Department of Cardiac Surgery, Lankenau Medical Center, Wynnewood, Pennsylvania, USA.

ORCID-Profile: Andrew Xanthopoulos, Dimitrios E Magouliotis, Katerina K Naka, Lampros K Michalis, Konstantinos Toutouzas, Serge Sicouri, Filippos Triposkiadis

Zitieren

APA

Xanthopoulos, A., Magouliotis, D. E., Naka, K. K., Michalis, L. K., Toutouzas, K., Sicouri, S., Ramlawi, B., Starling, R. C., Triposkiadis, F., Skoularigis, J., & Briasoulis, A. (2026). Regional Disparities and Unmet Needs in Long‐Term Durable Left Ventricular Assist Device Support Across Europe. Artificial Organs, 50(5), 730-737. https://doi.org/10.1111/aor.70077

Vancouver

Xanthopoulos A, Magouliotis DE, Naka KK, Michalis LK, Toutouzas K, Sicouri S, et al. Regional Disparities and Unmet Needs in Long‐Term Durable Left Ventricular Assist Device Support Across Europe. Artificial Organs. 2026;50(5):730-737. doi:10.1111/aor.70077

BibTeX
@article{Xanthopoulos2026,
  author = {Xanthopoulos, Andrew and Magouliotis, Dimitrios E and Naka, Katerina K and Michalis, Lampros K and Toutouzas, Konstantinos and Sicouri, Serge and Ramlawi, Basel and Starling, Randall C and Triposkiadis, Filippos and Skoularigis, John and Briasoulis, Alexandros},
  title = {Regional Disparities and Unmet Needs in Long‐Term Durable Left Ventricular Assist Device Support Across Europe},
  journal = {Artificial Organs},
  year = {2026},
  volume = {50},
  number = {5},
  pages = {730--737},
  doi = {10.1111/aor.70077}
}
Kostenlos starten →